Healthcare sector peers ranked by AI committee score · Updated nightly
| Symbol | Company | Sector | Score | Rating | Mkt Cap | P/E | Beta | Compare |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte | Healthcare | 70.4 | Strong Buy | $25.9B | 15.7 | 0.77 | Compare |
| GMED | Globus Medical | Healthcare | 68.7 | Buy | $11.3B | 21.2 | 0.95 | Compare |
| CDNA | CareDx, Inc | Healthcare | 68.5 | Buy | $2.5B | 22.1 | 2.42 | Compare |
| WST | West Pharmaceutical Services | Healthcare | 67.6 | Buy | $24.9B | 44.9 | 1.14 | Compare |
| ONC | BeOne Medicines AG | Healthcare | 67.5 | Buy | $39.7B | 27.3 | 0.50 | Compare |
| UTHR | United Therapeutics | Healthcare | 67.1 | Buy | $21.8B | 17.0 | 0.56 | Compare |
| ARGX | argenx SE | Healthcare | 67.1 | Buy | $62.9B | 37.0 | -0.02 | Compare |
| EXEL | Exelixis | Healthcare | 67.1 | Buy | $13.7B | 16.6 | 0.42 | Compare |
| MEDP | Medpace | Healthcare | 66.8 | Buy | $17.3B | 35.7 | 1.15 | Compare |
| SYRE | Spyre Therapeutics, Inc. | Healthcare | 66.7 | Buy | $9.3B | -54.7 | 3.03 | Compare |
| UHS | Universal Health Services | Healthcare | 66.4 | Buy | $10.7B | 7.2 | 1.06 | Compare |
| ABCL | AbCellera Biologics Inc. | Healthcare | 66.4 | Buy | $3.2B | -19.6 | 1.19 | Compare |
| SNY | Sanofi | Healthcare | 66.3 | Buy | $109.7B | 24.0 | 0.28 | Compare |
| ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | 66.0 | Buy | $5.1B | 13.2 | 0.84 | Compare |
| ZBH | Zimmer Biomet | Healthcare | 65.7 | Buy | $19.5B | 24.5 | 0.46 | Compare |
| ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | 65.6 | Buy | $3.1B | 112.2 | 1.53 | Compare |
| IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 65.3 | Buy | $3.6B | -11.5 | 0.70 | Compare |
| TMDX | TransMedics Group, Inc. | Healthcare | 64.9 | Buy | $3.2B | 21.2 | 1.88 | Compare |
| OMDA | Omada Health | Healthcare | 64.9 | Buy | $1.4B | 354.6 | 1.72 | Compare |
| MANE | Veradermics, Incorporated | Healthcare | 64.8 | Buy | $4.1B | -46.0 | 1.35 | Compare |
Why These Stocks?
These companies operate in the same Healthcare sector as Dexcom. Rankings are based on the latest AI committee score. View DXCM full analysis →